Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 5, 2009, Pages 479-488

  Thi, Thao Do ^a   Van Speybroeck, Michiel ^a   Barillaro, Valery ^a   Martens, Johan ^b   Annaert, Pieter ^a   Augustijns, Patrick ^a   Van Humbeeck, Jan ^b   Vermant, Jan ^b   Van den Mooter, Guy ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Dialysis; Formulation; In vitro release; SMEDDS

Indexed keywords

CARBAMAZEPINE; CREMOPHOR; DANAZOL; DIAZEPAM; FENOFIBRATE; GRISEOFULVIN; INDOMETACIN; ITRACONAZOLE; METHYLPREDNISOLONE; NIFEDIPINE; OCTANOIN; PHENYTOIN; POLYSORBATE 80; SOYBEAN OIL;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; MICELLIZATION; MICROEMULSION; MOLECULAR WEIGHT; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ZETA POTENTIAL;

CHEMISTRY, PHARMACEUTICAL; DIALYSIS; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; EMULSIFYING AGENTS; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; LIPIDS; MOLECULAR WEIGHT; PHARMACEUTICAL PREPARATIONS; PHYSICOCHEMICAL PHENOMENA; SOLUBILITY;

EID: 70449528399     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.09.012     Document Type: Article

References (32)

1. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
2. Cabrera C.G., de Waisbaum R.G., and Nudelman N.S. Kinetic and mechanistic studies on the hydrolysis and photodegradation of diazepam and alprazolamy. J. Phys. Org. Chem. 18 (2005) 156-161
3. Charman S.A., Charman W.N., Rogge M.C., Wilson T.D., Dutko F.J., and Pouton C.W. Self-emulsifying systems: formulation and biological evaluation of an investigative lipophilic compound. Pharm. Res. 9 (1992) 87-94
4. Charman W.N. Lipids, lipophilic drugs and oral delivery-some emerging concepts. J. Pharm. Sci. 89 (2000) 967-978
5. Chen M.L. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv. Drug. Dev. Rev. 60 (2008) 768-777
6. Chen Y., Li G., Wu X., Chen Z., Heng J., Qin B., Chen S., and Wang R. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol. Pharm. Bull. 31 (2008) 118-125
7. Constantinides P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12 (1995) 1561-1572
8. Craig D.M.Q. The use of self-emulsifying as a means of improving drug delivery. Bull. Tech. Gattefosse 86 (1993) 21-31
9. Gershanik T., and Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 50 (2000) 179-188
10. Goddeeris C., Coacci J., and Van den Mooter G. Correlation between digestion of the lipid phase of SMEDDS and release of the anti-HIV drug UV 781 and the anti-mycotic drug enilconazole from SMEDDS. Eur. J. Pharm. Biopharm. 66 (2007) 173-181
11. Greiner R.W., and Evans D.F. Spontaneous formation of a water-continuous emulsion from water-in-oil microemulsion. Langmuir 6 (1990) 1793-1796
12. Grevel J., Nuesch E., Abisch E., and Kuts K. Pharmacokinetics of oral cyclosporine A (Sandimmun) in healthy subjects. Eur. J. Clin. Pharmacol. 31 (1986) 211-216
13. Humberstone A.J., and Charman W.N. Lipid-based vehicles for oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 25 (1997) 103-128
14. Jantratid E., Janssen N., Chikshi H., Tang K., and Dressman J.B. Designing biorelevant dissolution tests for lipid formulations: case example-lipid suspension of RZ-50. Eur. J. Pharm. Biopharm. 69 (2008) 776-785
15. Kang B.K., Lee J.S., Chon S.K., Jeong S.Y., Yuk S.H., Khang G., Lee S.H.B., and Cho H. Development of self-micro-emulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 274 (2004) 65-73
16. Mu L., Elbayoumi T.A., and Torchilin V.P. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int. J. Pharm. 306 (2005) 142-149
17. Nicolaides E., Symillides M., Dressman J.B., and Reppas C. Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm. Res. 18 (2001) 380-388
18. O'Driscoll C.M. Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 15 (2002) 405-415
19. O'Driscoll C.M., and Griffin B.T. Biopharmaceutical challenges associated with drugs with low aqueous solubility-the potential impact of lipid-based formulation. Adv. Drug Dev. Rev. 60 (2008) 617-624
20. Porter C.J.H., and Charman W.N. In vitro assessment of oral lipid-based formulation. Adv. Drug Deliv. Rev. 50 (2001) S127-S147
21. Porter C.J.H., Kaukonen A.M., Boyd B.J., Edwards G.A., and Charman W.N. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm. Res. 21 (2004) 1405-1412
22. Porter C.J.H., Trevaski N.L., and Charman W.N. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6 (2007) 231-248
23. Pouton C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. (2000) S93-S98
24. Shah N.H., Carvajal M.T., Patel C.I., Infeld M.H., and Melick A.W. Self-emulsifying drug delivery systems with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 106 (1994) 15-23
25. Shen H., and Zhong M. Preparation and evaluation of self-emulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol. 58 (2006) 1183-1191
26. Tarr B.D., and Yalkowsky S.H. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm. Res. 6 (1989) 40-43
27. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73 (2001) 137-172
28. Uede C.T., Lemaire M., Gsell G., Misslin P., and Nussbaumer K. Apparent dose-dependent oral absorption of cyclosporine A in rats. Biopharm. Drug Dispos. 5 (1984) 141-151
29. Vanderscher J., and Meinzer A. Rationale for the development of Sandimmune Neoral. Transplant. Proc. 26 (1994) 2925-2927
30. Vetter R.D., Carey M.C., and Patton J.S. Coassimilation of dietary fat and benzopyrene in the small intestine: an absorption model using killifish. J. Lipid Res. 26 (1985) 428-434
31. Wassan K.M. Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems. Drug Dev. Ind. Pharm. 27 (2001) 267-276
32. Woo J.S., Kim T., Park J., and Chi S. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. Arch. Pharm. Res. 30 (2007) 82-89